Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163358
Status:
COMPLETED
Last Update Posted:
2016-11-30
First Post:
2005-09-12
Brief Title:
Efficacy of Ciclesonide vs Fixed Combination of Fluticasone PropionateSalmeterol vs Placebo in Patients With Mild Persistent Asthma 12 to 75 y BY9010M1-132
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Efficacy of Ciclesonide and of a Fixed Combination With Fluticasone Propionate and Salmeterol Versus Placebo on Long-term Asthma Control
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to compare the efficacy of ciclesonide versus fixed combination of fluticasone propionatesalmeterol versus placebo on long-term asthma control in patients with mild persistent asthma The study duration consists of a baseline period 2 weeks and a treatment period 12 months The study will provide further data on safety and tolerability of ciclesonide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None